VivaQuant Receives FDA 510(k) Clearance for its RX-1 Rhythm ExpressTM Arrhythmia Device

62

ST. PAUL, Minn.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CardiacMonitor?src=hash" target="_blank"gt;#CardiacMonitorlt;/agt;–VivaQuant, a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, has received FDA clearance for its RX-1 wearable device. RX-1 continuously monitors a patient’s ECG as they go about their normal daily activities, identifies arrhythmias, and communicates the information to the cloud using a built-in cellular connection. Skilled staff in a US-based monitoring center review the incoming data and re http://www.businesswire.com/news/home/20190430005087/en/VivaQuant-Receives-FDA-510-Clearance-RX-1-Rhythm/?feedref=JjAwJuNHiystnCoBq_hl-WFAllVCLJFCqzlmaJ8DKHU4plfPZtlGYRDUHCSmgbii6XkLWuQZD-HgGRnjQvCyg3iCfEFIaJW7-otp9V1XQiK2eHTJy3ZqOEt7kKgLu20J